Asset Management One Taps Ullink for Xilix Pre-Trade Risk, Compliance

Japanese investment group implements pre-trade risk and compliance elements of Ullink’s Xilix execution management system.

tokyo-2020-sunset
Headquartered in Tokyo, Asset Management One was established via merger in October last year.

Asset Management One has deployed the Xilix EMS pre-trade risk and compliance tools to perform pre-trade, cross-order and large volume compliance checks on multiple orders across various different trading systems, in addition to transparency and best execution functions.

The firm was established in October 2016 through the merger of DIAM Asset Management, Mizuho Trust and Banking (asset management division), Mizuho Asset Management and Shinko Asset Management.

"We have been using Ullink's Xilix service for a long time now," said Hiroshi Yabuta, Asset Management One executive officer, IT system, administrative division manager, and trading group executive officer, in a statement. "As a solution it was critical that Xilix not only has the appropriate functionality, but it has the long-term development, customer trust, and same thought process we have with regard to scalability."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here